Catalyst Funds Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Catalyst Funds Management's IDXX Position: Q3 2026 in Review
Catalyst Funds Management sold out of Idexx Laboratories (IDXX) in Q3 2026, closing a stake of 1,821 shares — an estimated $959K sold.
Catalyst Funds Management first reported a position in IDXX in Q2 2025 and held it in 3 quarters. The position peaked at $959K in Q2 2026. 1,272 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- Catalyst Funds Management reported no remaining Idexx Laboratories position as of Q3 2026 after selling out during the quarter.
- Catalyst Funds Management sold 1,821 Idexx Laboratories shares in Q3 2026, an estimated $959K.
- Catalyst Funds Management first reported a position in Idexx Laboratories in Q2 2025 and held it in 3 quarters.
- Catalyst Funds Management's Idexx Laboratories position peaked at $959K in Q2 2026.
- 1,272 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on Catalyst Funds Management's 13F filing for Q3 2026, filed 12 Nov 2026.